Aktis Oncology (AKTS) Q2 2026 Earnings

May 11Confirmed
Q3 2024
Q1 2025
Q4 2025
Q2 2026
-60.17
-40.13
-20.1
-0.06

Details

Expected EPS
-0.36154
Actual EPS
-0.38
Surprise EPS
-0.02
Surprise Percent
-5.11%

Description

⁨Aktis Oncology⁩ (⁦AKTS⁩) has reported earnings of ⁦-0.38⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts